Community Research Initiative (CRI) is an independent, nonprofit, community-based organization in New England dedicated to HIV and hepatitis C clinical research, treatment education, and financial assistance for approved HIV drug treatments and health insurance coverage.
Thanks to you, CRI participated in an innovative study whose results were just released. The START (Strategic Timing of Antiretroviral Treatment) study results show that people with HIV should start antiretroviral (ARV) therapy as soon as possible after diagnosis to avoid developing AIDS and opportunistic infections. START is the first major randomized clinical trial to produce definitive evidence showing that HIV-positive people who start treatment immediately after diagnosis will be healthier and live longer. This important data is the collective effort of hundreds of research staff, thousands of study participants, and you—because your support makes CRI’s research possible. Thank you!
HDAP staff, in collaboration with the Office of HIV/AIDS (OHA) of the Massachusetts Department of Public Health, have recently conducted two webinars to provide information on HDAP and the ACA, navigating the new MA Health Connector, and on special considerations for clients with HIV and their case managers. Click "Read More" to find out how to view these webinars.
Registration for Harbor to the Bay Ride 13 is now open! Join the fun and camaraderie while making an incredible difference on Saturday, September 19, 2015. Register at www.harbortothebay.org with Team CRI, and don't forget to name Community Research Initiative as your beneficiary. CRI conducts clinical research because of the people who benefit from it, and our work is only possible with the help of the riders, crew members, donors, volunteers, and people like you. Thank you!